Challenges in Identifying Uncommon Clinical Isolates of Candida Species Using Conventional Phenotypic Methods: A...

Area of Science:

• Medical Mycology
• Clinical Microbiology
• Infectious Diseases

Background:

• Non-albicans Candida species are emerging as significant pathogens, often displaying multidrug resistance.
• Accurate Candida speciation is critical for effective treatment, yet conventional methods persist despite known limitations.
• Resource-poor settings face challenges in implementing advanced diagnostic techniques for fungal infections.

Purpose of the Study:

• To compare the accuracy of conventional phenotypic methods, chromogenic media, and the VITEK 2 compact system for Candida speciation.
• To assess antifungal susceptibility patterns of clinical Candida isolates in a rural tertiary care hospital.
• To evaluate the diagnostic performance of different methods, particularly for emerging species like Candida auris.

Main Methods:

• Prospective cross-sectional study involving isolation of Candida from clinical specimens (blood, urine, sputum, pus).
• Speciation using conventional phenotypic tests, HiCrome Candida differential agar, and VITEK 2 compact system.
• Antifungal susceptibility testing via disc diffusion method on Mueller-Hinton agar.

Main Results:

• 78 Candida isolates were identified; non-albicans species predominated, with Candida tropicalis being most common (n=53).
• Conventional and chromogenic methods showed varying accuracy and failed to identify Candida auris (n=2).
• High resistance rates observed for fluconazole (57.7%), itraconazole (66.7%), and voriconazole (60.3%), with higher resistance in non-albicans species.

Conclusions:

• Non-albicans Candida species are the primary cause of Candida infections in rural Haryana, India, necessitating accurate identification due to multidrug resistance.
• Conventional phenotypic and chromogenic methods are inadequate for accurate speciation, especially for challenging species like Candida auris.
• The study underscores the need for advanced diagnostic tools in resource-limited settings to combat rising antifungal resistance in Candida infections.